The Impact of COVID-19 is included in Head and Neck Cancer Diagnostic Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Head and Neck Cancer Diagnostic Trends and Forecast
The future of the global head and neck cancer diagnostic market looks promising with opportunities in the hospital, ambulatory surgical center, and diagnostic center markets. The global head and neck cancer diagnostic market is expected to reach an estimated $3.4 billion by 2030 with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are increasing prevalence of head and neck cancer, surhing access to healthcare, and growing awareness of the signs and symptoms of head and neck cancer, as well as the importance of early detection.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Head and Neck Cancer Diagnostic by Segment
The study includes a forecast for the global head and neck cancer diagnostic by type, diagnosis, treatment, end use, and region.
Head and Neck Cancer Diagnostic Market by Type [Shipment Analysis by Value from 2018 to 2030]:
• Laryngeal Cancer
• Pharyngeal Cancer
• Salivary Gland Cancer
• Lip & Oral Cavity Cancer
• Nasopharyngeal Cancer
• Others
Head and Neck Cancer Diagnostic Market by Diagnosis [Shipment Analysis by Value from 2018 to 2030]:
• Bioscopy Screening Tests
• Blood Tests
• Dental Diagnosis
• Imaging
• Endoscopy
Head and Neck Cancer Diagnostic Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:
• Chemotherapy
• Radiation Therapy
• Targeted Therapy
• Surgery
• Others
Head and Neck Cancer Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers
• Others
Head and Neck Cancer Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Head and Neck Cancer Diagnostic Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies head and neck cancer diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the head and neck cancer diagnostic companies profiled in this report include-
• GE Healthcare
• Philips
• Siemens Healthineeer
• Merck
• Eli Lilly
Head and Neck Cancer Diagnostic Market Insights
Lucintel forecasts that imaging is expected to witness highest growth over the forecast period.
Within this market, hospitals will remain the largest segment because it has better disease diagnosis capabilities and also have the latest medical equipment and technology, which allows them to provide patients with the best possible care.
North America will remain the largest region during the forecast period due to the presence of a strong healthcare infrastructure, favorable reimbursement policies, high awareness about the disease, and government support for the development of the healthcare sector.
Features of the Global Head and Neck Cancer Diagnostic Market
Market Size Estimates: Head and neck cancer diagnostic market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Head and neck cancer diagnostic market size by various segments, such as by type, diagnosis, treatment, end use, and region in terms of ($B).
Regional Analysis: Head and neck cancer diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, diagnosis, treatments, end uses, and regions for the head and neck cancer diagnostic market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the head and neck cancer diagnostic market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the head and neck cancer diagnostic market size?
Answer: The global head and neck cancer diagnostic market is expected to reach an estimated 3.4 billion by 2030.
Q.2 What is the growth forecast for head and neck cancer diagnostic market?
Answer: The global head and neck cancer diagnostic market is expected to grow with a CAGR of 7.1% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the head and neck cancer diagnostic market?
Answer: The major drivers for this market are increasing prevalence of head and neck cancer, surhing access to healthcare, and growing awareness of the signs and symptoms of head and neck cancer, as well as the importance of early detection.
Q4. What are the major segments for head and neck cancer diagnostic market?
Answer: The future of the head and neck cancer diagnostic market looks promising with opportunities in the hospital, ambulatory surgical center, and diagnostic center markets.
Q5. Who are the key head and neck cancer diagnostic market companies?
Answer: Some of the key head and neck cancer diagnostic companies are as follows:
• GE Healthcare
• Philips
• Siemens Healthineeer
• Merck
• Eli Lilly
Q6. Which head and neck cancer diagnostic market segment will be the largest in future?
Answer: Lucintel forecasts that imaging is expected to witness highest growth over the forecast period.
Q7. In head and neck cancer diagnostic market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region during the forecast period due to the presence of a strong healthcare infrastructure, favorable reimbursement policies, high awareness about the disease, and government support for the development of the healthcare sector.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the head and neck cancer diagnostic market by type (laryngeal cancer, pharyngeal cancer, salivary gland cancer, lip & oral cavity cancer, nasopharyngeal cancer, and others), diagnosis (bioscopy screening tests, blood tests, dental diagnosis, imaging, and endoscopy), treatment (chemotherapy, radiation therapy, targeted therapy, surgery, and others), end use (hospitals, ambulatory surgical centers, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Head And Neck Cancer Diagnostic Market, Head And Neck Cancer Diagnostic Market Size, Head And Neck Cancer Diagnostic Market Growth, Head And Neck Cancer Diagnostic Market Analysis, Head And Neck Cancer Diagnostic Market Report, Head And Neck Cancer Diagnostic Market Share, Head And Neck Cancer Diagnostic Market Trends, Head And Neck Cancer Diagnostic Market Forecast, Head And Neck Cancer Diagnostic Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Head and Neck Cancer Diagnostic Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Head and Neck Cancer Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Head and Neck Cancer Diagnostic Market by Type
3.3.1: Laryngeal Cancer
3.3.2: Pharyngeal Cancer
3.3.3: Salivary Gland Cancer
3.3.4: Lip & Oral Cavity Cancer
3.3.5: Nasopharyngeal Cancer
3.3.6: Others
3.4: Global Head and Neck Cancer Diagnostic Market by Diagnosis
3.4.1: Bioscopy Screening Tests
3.4.2: Blood Tests
3.4.3: Dental Diagnosis
3.4.4: Imaging
3.4.5: Endoscopy
3.5: Global Head and Neck Cancer Diagnostic Market by Treatment
3.5.1: Chemotherapy
3.5.2: Radiation Therapy
3.5.3: Targeted Therapy
3.5.4: Surgery
3.5.5: Others
3.6: Global Head and Neck Cancer Diagnostic Market by End Use
3.6.1: Hospitals
3.6.2: Ambulatory Surgical Centers
3.6.3: Diagnostic Centers
3.6.4: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Head and Neck Cancer Diagnostic Market by Region
4.2: North American Head and Neck Cancer Diagnostic Market
4.2.2: North American Head and Neck Cancer Diagnostic Market by End Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others
4.3: European Head and Neck Cancer Diagnostic Market
4.3.1: European Head and Neck Cancer Diagnostic Market by Diagnosis : Bioscopy Screening Tests, Blood Tests, Dental Diagnosis, Imaging, and Endoscopy
4.3.2: European Head and Neck Cancer Diagnostic Market by End Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others
4.4: APAC Head and Neck Cancer Diagnostic Market
4.4.1: APAC Head and Neck Cancer Diagnostic Market by Diagnosis : Bioscopy Screening Tests, Blood Tests, Dental Diagnosis, Imaging, and Endoscopy
4.4.2: APAC Head and Neck Cancer Diagnostic Market by End Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others
4.5: ROW Head and Neck Cancer Diagnostic Market
4.5.1: ROW Head and Neck Cancer Diagnostic Market by Diagnosis : Bioscopy Screening Tests, Blood Tests, Dental Diagnosis, Imaging, and Endoscopy
4.5.2: ROW Head and Neck Cancer Diagnostic Market by End Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by Type
6.1.2: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by Diagnosis
6.1.3: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by Treatment
6.1.4: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by End Use
6.1.5: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by Region
6.2: Emerging Trends in the Global Head and Neck Cancer Diagnostic Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Head and Neck Cancer Diagnostic Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Head and Neck Cancer Diagnostic Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: GE Healthcare
7.2: Philips
7.3: Siemens Healthineeer
7.4: Merck
7.5: Eli Lilly
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Head and Neck Cancer Diagnostic Market Report.